Form 8-K - Current report:
SEC Accession No. 0001104659-25-049925
Filing Date
2025-05-16
Accepted
2025-05-16 12:38:24
Documents
14
Period of Report
2025-05-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515108d1_8k.htm   iXBRL 8-K 37121
5 GRAPHIC tm2515108d1_8kimg001.jpg GRAPHIC 3786
  Complete submission text file 0001104659-25-049925.txt   223422

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA optn-20250516.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE optn-20250516_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE optn-20250516_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2515108d1_8k_htm.xml XML 3677
Mailing Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067
Business Address 777 TOWNSHIP LINE ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

EIN.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 25957939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)